Terms: = Cervical cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
10 results:
1. The Tumor Suppressor brca1/2, cancer Susceptibility and Genome Instability in Gynecological and Mammary cancers.
Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for cervical cancer.
Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
[TBL] [Abstract] [Full Text] [Related]
3. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis.
Zhou R; Wei C; Liu J; Luo Y; Tang W
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():210-213. PubMed ID: 26595307
[TBL] [Abstract] [Full Text] [Related]
5. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix.
Chen J; Macdonald OK; Gaffney DK
Obstet Gynecol; 2008 Jun; 111(6):1394-402. PubMed ID: 18515524
[TBL] [Abstract] [Full Text] [Related]
6. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract] [Full Text] [Related]
8. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome.
Narayan G; Arias-Pulido H; Koul S; Vargas H; Zhang FF; Villella J; Schneider A; Terry MB; Mansukhani M; Murty VV
Mol Cancer; 2003 May; 2():24. PubMed ID: 12773202
[TBL] [Abstract] [Full Text] [Related]
9. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
[TBL] [Abstract] [Full Text] [Related]
10. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
[TBL] [Abstract] [Full Text] [Related]